Data / Form D filings / ECLIPSE BIOINNOVATIONS, INC.
ECLIPSE BIOINNOVATIONS, INC.: Form D filings
ECLIPSE BIOINNOVATIONS, INC., a biotechnology company in San Diego, CA, filed 2 Form D notices with the SEC between 2021 and 2025. The latest, on November 20, 2025, reports $4.9 million sold of a $7.2 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5770 Oberlin Dr., San Diego, CA, 92121
- Phone
- (858) 768-0699
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1881936
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | New notice | $7,235,074 | $4,905,886 | $2,329,188 | 7 | Nov 5, 2025 | sec.gov |
| Sep 10, 2021 | New notice | $14,950,020 | $11,950,024 | $2,999,996 | 10 | Aug 27, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Chu | Executive Officer, Director | |
| Daniel Vasella | Director | |
| Edmond Wong | Director | |
| Eugene Yeo | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ECLIPSE BIOINNOVATIONS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.